| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 124 |
| 1 | INFLIXIMAB | 114 |
| 2 | PREDNISONE | 109 |
| 3 | BEVACIZUMAB | 88 |
| 4 | METRONIDAZOLE | 80 |
| 5 | CARBOPLATIN | 65 |
| 6 | CIPROFLOXACIN HYDROCHLORIDE | 63 |
| 7 | METHOTREXATE SODIUM | 60 |
| 8 | CIPROFLOXACIN | 57 |
| 9 | ACETAMINOPHEN | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE | 1 | 0.0132 |
| 1 | BUPIVACAINE AND MELOXICAM | 2 | 0.0094 |
| 2 | BRINCIDOFOVIR | 1 | 0.0072 |
| 3 | BISACODYL 5MG | 6 | 0.0069 |
| 4 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | 1 | 0.0048 |
| 5 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0047 |
| 6 | ARFORMOTEROL TARTRATE | 1 | 0.0042 |
| 7 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 30 | 0.0036 |
| 9 | DIMETICONE | 1 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 250 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 172 |
| 2 | Platinum-based Drug [EPC] | 120 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 108 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 100 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 95 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 80 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 59 |
| 8 | Benzodiazepine [EPC] | 55 |
| 9 | Microtubule Inhibitor [EPC] | 51 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 1 | Nitroimidazole Antimicrobial [EPC] | 80 | 0.0012 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 3 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 4 | Stimulant Laxative [EPC] | 12 | 0.0008 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 10 | 0.0008 |
| 6 | Antihypoglycemic Agent [EPC] | 3 | 0.0007 |
| 7 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 8 | Antiseptic [EPC] | 3 | 0.0007 |
| 9 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |